This collaboration, initially unveiled in 2022 and briefly highlighted ahead of the UN’s Sustainable Development Goals (SDG) Summit, has remained mostly unacknowledged by the mainstream media.
U.S. federal government has imposed a stringent 10-year funding prohibition on the Wuhan Institute of Virology (WIV) through the Health and Human Services Department (HHS).
Neuralink has received the green light to initiate recruitment for its inaugural human clinical trial, dubbed the PRIME Study (Precise Robotically Implanted Brain-Computer Interface).
Critics argue that the PPPR is marred by contradictions and emphasizes an unwarranted centralization of control at the expense of democracy and human rights.
